Bifurcations and Chaotic Dynamics in a Tumour-Immune-Virus System
暂无分享,去创建一个
Jonathan Dushoff | David J. D. Earn | Cicely K. Macnamara | Raluca Eftimie | Jonathan L. Bramson | J. Dushoff | D. Earn | R. Eftimie | J. Bramson | Cicely Krystyna Macnamara
[1] R. Coffin. Oncolytic immunotherapy: an emerging new modality for the treatment of cancer. , 2016, Annals of oncology : official journal of the European Society for Medical Oncology.
[2] Ivo P. Janecka,et al. Cancer control through principles of systems science, complexity, and chaos theory: A model , 2007, International journal of medical sciences.
[3] H. Atkins,et al. Targeted inflammation during oncolytic virus therapy severely compromises tumor blood flow. , 2007, Molecular therapy : the journal of the American Society of Gene Therapy.
[4] L. Glass,et al. Oscillation and chaos in physiological control systems. , 1977, Science.
[5] L. D. Pillis,et al. A Validated Mathematical Model of Cell-Mediated Immune Response to Tumor Growth , 2005 .
[6] S. Russell,et al. PEGylation of Vesicular Stomatitis Virus Extends Virus Persistence in Blood Circulation of Passively Immunized Mice , 2013, Journal of Virology.
[7] H. Pircher,et al. On the role of antigen in maintaining cytotoxic T-cell memory. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[8] T. Pham,et al. Spatial chaos and complexity in the intracellular space of cancer and normal cells , 2013, Theoretical Biology and Medical Modelling.
[9] A. Radunskaya,et al. A Model of Dendritic Cell Therapy for Melanoma , 2013, Front. Oncol..
[10] Dominik Wodarz,et al. Towards Predictive Computational Models of Oncolytic Virus Therapy: Basis for Experimental Validation and Model Selection , 2009, PloS one.
[11] A. Wolf,et al. Determining Lyapunov exponents from a time series , 1985 .
[12] G. Nicolson,et al. Experimental Brain Metastasis , 1980 .
[13] E. Lorenz. Deterministic nonperiodic flow , 1963 .
[14] M. Quinn,et al. CRP identifies homeostatic immune oscillations in cancer patients: a potential treatment targeting tool? , 2009, Journal of Translational Medicine.
[15] J. Holland,et al. The intracellular half-lives of nonreplicating nucleocapsids of DI particles of wild type and mutant strains of vesicular stomatitis virus. , 1986, Virology.
[16] Urszula Ledzewicz,et al. AntiAngiogenic Therapy in Cancer Treatment as an Optimal Control Problem , 2007, SIAM J. Control. Optim..
[17] N. Rashevsky,et al. Mathematical biology , 1961, Connecticut medicine.
[18] J. Bell,et al. Recent progress in the battle between oncolytic viruses and tumours , 2005, Nature Reviews Cancer.
[19] R. Vile,et al. Dynamics of melanoma tumor therapy with vesicular stomatitis virus: explaining the variability in outcomes using mathematical modeling , 2011, Gene Therapy.
[20] M. Bevan,et al. Effector and memory CTL differentiation. , 2007, Annual review of immunology.
[21] J A Sherratt,et al. Modelling the macrophage invasion of tumours: effects on growth and composition. , 1998, IMA journal of mathematics applied in medicine and biology.
[22] Joanna R. Wares,et al. Quantitative impact of immunomodulation versus oncolysis with cytokine-expressing virus therapeutics. , 2015, Mathematical biosciences and engineering : MBE.
[23] F. Carraro,et al. Role of inflammatory mediators in angiogenesis. , 2005, Current drug targets. Inflammation and allergy.
[24] H. Pircher,et al. Solid tumors “melt” from the inside after successful CD8 T cell attack , 2006, European journal of immunology.
[25] Natalia L. Komarova,et al. Complex Spatial Dynamics of Oncolytic Viruses In Vitro: Mathematical and Experimental Approaches , 2012, PLoS Comput. Biol..
[26] Helen M. Byrne,et al. Macrophage-tumour interactions: in vivo dynamics , 2003 .
[27] Miguel A F Sanjuán,et al. A Validated Mathematical Model of Tumor Growth Including Tumor–Host Interaction, Cell-Mediated Immune Response and Chemotherapy , 2014, Bulletin of Mathematical Biology.
[28] C. J. Gordon,et al. Baseline tumor growth and immune control in laboratory mice are significantly influenced by subthermoneutral housing temperature , 2013, Proceedings of the National Academy of Sciences.
[29] Svetlana Bunimovich-Mendrazitsky,et al. Mathematical Model of BCG Immunotherapy in Superficial Bladder Cancer , 2007, Bulletin of mathematical biology.
[30] M. Wicha,et al. Cancer stem cells: a step toward the cure. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[31] James D. Murray. Mathematical Biology: I. An Introduction , 2007 .
[32] P. Beverley. Primer: making sense of T-cell memory , 2008, Nature Clinical Practice Rheumatology.
[33] A. Dalgleish,et al. The relevance of non-linear mathematics (chaos theory) to the treatment of cancer, the role of the immune response and the potential for vaccines. , 1999, QJM : monthly journal of the Association of Physicians.
[34] Mads Kærn,et al. Model-based rational design of an oncolytic virus with improved therapeutic potential , 2013, Nature Communications.
[35] Zeljko Bajzer,et al. Modeling of cancer virotherapy with recombinant measles viruses. , 2008, Journal of theoretical biology.
[36] Z Bajzer,et al. Dynamics of multiple myeloma tumor therapy with a recombinant measles virus , 2009, Cancer Gene Therapy.
[37] Dominik Wodarz,et al. Computational modeling approaches to studying the dynamics of oncolytic viruses. , 2013, Mathematical biosciences and engineering : MBE.
[38] B. Benacerraf,et al. Blood clearance of P32-labeled vesicular stomatitis and Newcastle disease viruses by the reticuloendothelial system in mice. , 1960, Journal of immunology.
[39] L A Aguirre,et al. What can be learned from a chaotic cancer model? , 2013, Journal of theoretical biology.
[40] R. Kratzke,et al. Oncolytic virus therapy for cancer: the first wave of translational clinical trials. , 2013, Translational research : the journal of laboratory and clinical medicine.
[41] Lawrence M Wein,et al. Validation and analysis of a mathematical model of a replication-competent oncolytic virus for cancer treatment: implications for virus design and delivery. , 2003, Cancer research.
[42] S. Boccaletti,et al. The control of chaos: theory and applications , 2000 .
[43] S. Rosenberg,et al. Cancer immunotherapy: moving beyond current vaccines , 2004, Nature Medicine.
[44] S. Russell,et al. ONCOLYTIC VIROTHERAPY , 2012, Nature Biotechnology.
[45] D. Earn,et al. Modeling anti-tumor Th1 and Th2 immunity in the rejection of melanoma. , 2010, Journal of theoretical biology.
[46] D. Wodarz,et al. Viruses as antitumor weapons: defining conditions for tumor remission. , 2001, Cancer research.
[47] Y. Soini,et al. A high number of tumor-infiltrating lymphocytes are associated with a small tumor size, low tumor stage, and a favorable prognosis in operated small cell lung carcinoma. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.
[48] R. Ahmed,et al. Models of immune memory: on the role of cross-reactive stimulation, competition, and homeostasis in maintaining immune memory. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[49] J S Spratt,et al. Decelerating growth and human breast cancer , 1993, Cancer.
[50] Eleanor Pullenayegum,et al. Potentiating cancer immunotherapy using an oncolytic virus. , 2010, Molecular therapy : the journal of the American Society of Gene Therapy.
[51] T. Mattfeldt. Nonlinear deterministic analysis of tissue texture: a stereological study on mastopathic and mammary cancer tissue using chaos theory , 1997, Journal of microscopy.
[52] G. Silvestri,et al. Differential innate immune responses to low or high dose oral SIV challenge in Rhesus macaques. , 2011, Current HIV research.
[53] A. Mackensen,et al. Effector function of human tumor-specific CD8 T cells in melanoma lesions: a state of local functional tolerance. , 2004, Cancer research.
[54] S. Friberg,et al. REVIEW ARTICLE On the Growth Rates of Human Malignant Tumors: Implications for Medical Decision Making , 1997 .
[55] D. Earn,et al. Interactions Between the Immune System and Cancer: A Brief Review of Non-spatial Mathematical Models , 2011, Bulletin of mathematical biology.
[56] F. Wong-Staal,et al. Oncolytic virotherapy as a personalized cancer vaccine , 2008, International journal of cancer.
[57] Philip Hahnfeldt,et al. Modeling the Dichotomy of the Immune Response to Cancer: Cytotoxic Effects and Tumor-Promoting Inflammation , 2013, Bulletin of mathematical biology.
[58] L. Wein,et al. Modeling and analysis of a virus that replicates selectively in tumor cells , 2001, Bulletin of mathematical biology.
[59] P. Hahnfeldt,et al. Tumor development under angiogenic signaling: a dynamical theory of tumor growth, treatment response, and postvascular dormancy. , 1999, Cancer research.
[60] G. Kobinger,et al. PEGylation of a Vesicular Stomatitis Virus G Pseudotyped Lentivirus Vector Prevents Inactivation in Serum , 2004, Journal of Virology.
[61] D L S McElwain,et al. A history of the study of solid tumour growth: The contribution of mathematical modelling , 2004, Bulletin of mathematical biology.
[62] B. Ovbiagele,et al. Drug Insight: translating evidence on statin therapy into clinical benefits , 2008, Nature Clinical Practice Neurology.
[63] H. Schreiber,et al. Innate and adaptive immune cells in the tumor microenvironment , 2013, Nature Immunology.
[64] D. Kirschner,et al. Modeling immunotherapy of the tumor – immune interaction , 1998, Journal of mathematical biology.
[65] Jonathan Dushoff,et al. Multi-Stability and Multi-Instability Phenomena in a Mathematical Model of Tumor-Immune-Virus Interactions , 2011, Bulletin of mathematical biology.
[66] R. Labianca,et al. Evidence for cure by adjuvant therapy in colon cancer: observations based on individual patient data from 20,898 patients on 18 randomized trials. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[67] K. Pienta,et al. Cancer as a complex adaptive system. , 1996, Medical hypotheses.
[68] D. Schaffer,et al. Engineering a serum-resistant and thermostable vesicular stomatitis virus G glycoprotein for pseudotyping retroviral and lentiviral vectors , 2013, Gene Therapy.